{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:01:45Z","timestamp":1793721705759,"version":"4.6.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Employee of H Lundbeck A\/S"},{"DOI":"10.13039\/501100013327","name":"H Lundbeck A\/S","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"crossref"}]},{"name":"H Lundebeck A\/S"},{"name":"AllerGen (CA)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12888-017-1523-8","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T00:40:58Z","timestamp":1511224858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["An ethnographic study of the effects of cognitive symptoms in patients with major depressive disorder: the IMPACT study"],"prefix":"10.1186","volume":"17","author":[{"given":"Bjarke","family":"Ebert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilla","family":"Miskowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Kloster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Eckholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"W\u00e6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Holme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise Meldgaard","family":"Bruun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"issue":"10","key":"1523_CR1","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.2174\/1871527313666141130203823","volume":"13","author":"B Bortolato","year":"2014","unstructured":"Bortolato B, Carvalho AF, McIntyre RS. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review. CNS Neurol Disord Drug Targets. 2014;13(10):1804\u201318.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"6","key":"1523_CR2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/da.22063","volume":"30","author":"RS McIntyre","year":"2013","unstructured":"McIntyre RS, Cha DS, Soczynska JK, Woldeyohannes HO, Gallaugher LA, Kudlow P, Alsuwaidan M, Baskaran A. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety. 2013;30(6):515\u201327.","journal-title":"Depress Anxiety"},{"issue":"3","key":"1523_CR3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1017\/S0033291712001511","volume":"43","author":"AJ Ferrari","year":"2013","unstructured":"Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, Whiteford HA. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013;43(3):471\u201381.","journal-title":"Psychol Med"},{"issue":"1","key":"1523_CR4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/da.20580","volume":"27","author":"HG Birnbaum","year":"2010","unstructured":"Birnbaum HG, Kessler RC, Kelley D, Ben-Hamadi R, Joish VN, Greenberg PE. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depress Anxiety. 2010;27(1):78\u201389.","journal-title":"Depress Anxiety"},{"issue":"4","key":"1523_CR5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/JOM.0000000000000112","volume":"56","author":"CA Bouwmans","year":"2014","unstructured":"Bouwmans CA, Vemer P, van Straten A, Tan SS, Hakkaart-van Roijen L. Health-related quality of life and productivity losses in patients with depression and anxiety disorders. J Occup Environ Med. 2014;56(4):420\u20134.","journal-title":"J Occup Environ Med"},{"key":"1523_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jad.2015.03.004","volume":"178","author":"SM Hendriks","year":"2015","unstructured":"Hendriks SM, Spijker J, Licht CM, Hardeveld F, de Graaf R, Batelaan NM, Penninx BW, Beekman AT. Long-term work disability and absenteeism in anxiety and depressive disorders. J Affect Disord. 2015;178:121\u201330.","journal-title":"J Affect Disord"},{"issue":"18","key":"1523_CR7","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3109\/09638288.2014.973970","volume":"37","author":"PU Hjarsbech","year":"2015","unstructured":"Hjarsbech PU, Nielsen MB, Andersen MF, Rugulies R, Christensen U. Struggling at work - a qualitative study of working Danes with depressive symptoms. Disabil Rehabil. 2015;37(18):1674\u201382.","journal-title":"Disabil Rehabil"},{"issue":"6","key":"1523_CR8","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1176\/appi.ajp.162.6.1171","volume":"162","author":"MH Rapaport","year":"2005","unstructured":"Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry. 2005;162(6):1171\u20138.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1523_CR9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-0327(99)00153-6","volume":"59","author":"C Zlotnick","year":"2000","unstructured":"Zlotnick C, Kohn R, Keitner G, Della Grotta SA. The relationship between quality of interpersonal relationships and major depressive disorder: findings from the National Comorbidity Survey. J Affect Disord. 2000;59(3):205\u201315.","journal-title":"J Affect Disord"},{"key":"1523_CR10","first-page":"1","volume-title":"The low of the 21st century? - summary report","author":"The Global Crisis of Depression","year":"2014","unstructured":"The Global Crisis of Depression. The low of the 21st century? - summary report. Kings Place, London: The Economist Insights; 2014. p. 1\u201314."},{"issue":"2","key":"1523_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.14m09298","volume":"76","author":"PE Greenberg","year":"2015","unstructured":"Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76(2):155\u201362.","journal-title":"J Clin Psychiatry"},{"key":"1523_CR12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.comppsych.2014.08.051","volume":"56","author":"RS McIntyre","year":"2015","unstructured":"McIntyre RS, Soczynska JZ, Woldeyohannes HO, Alsuwaidan MT, Cha DS, Carvalho AF, et al. The impact of cognitive impairment on perceived workforce performance: results from the international mood disorders collaborative project. Compr Psychiatry. 2015;56:279\u201382.","journal-title":"Compr Psychiatry"},{"issue":"1","key":"1523_CR13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.psychres.2005.11.011","volume":"145","author":"J Jaeger","year":"2006","unstructured":"Jaeger J, Berns S, Uzelac S, Davis-Conway S. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res. 2006;145(1):39\u201348.","journal-title":"Psychiatry Res"},{"issue":"8","key":"1523_CR14","doi-asserted-by":"crossref","first-page":"e747","DOI":"10.4088\/JCP.12m08258","volume":"74","author":"M Vinberg","year":"2013","unstructured":"Vinberg M, Miskowiak KW, Kessing LV. Impairment of executive function and attention predicts onset of affective disorder in healthy high-risk twins. J Clin Psychiatry. 2013;74(8):e747\u2013e53.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"1523_CR15","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1017\/S0033291710001911","volume":"41","author":"HJ Conradi","year":"2011","unstructured":"Conradi HJ, Ormel J, de Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2011;41(6):1165\u201374.","journal-title":"Psychol Med"},{"issue":"1\u20133","key":"1523_CR16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jad.2009.10.009","volume":"123","author":"I Herrera-Guzman","year":"2010","unstructured":"Herrera-Guzman I, Gudayol-Ferre E, Herrera-Abarca JE, Herrera-Guzman D, Montelongo-Pedraza P, Padros BF, Pero-Cebollero M, Guardia-Olmos J. Major depressive disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with major depressive disorder in recovery. J Affect Disord. 2010;123(1\u20133):341\u201350.","journal-title":"J Affect Disord"},{"key":"1523_CR17","volume-title":"Work group on major depressive disorder. Practice guideline for the treatment of patients with major depressive disorder","author":"American Psychiatric Association (APA)","year":"2010","unstructured":"American Psychiatric Association (APA). Work group on major depressive disorder. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Arlington: American Psychiatric Association; 2010.","edition":"3"},{"issue":"7","key":"1523_CR18","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.4088\/JCP.9078tx1c","volume":"71","author":"AJ Gelenberg","year":"2010","unstructured":"Gelenberg AJ. A review of the current guidelines for depression treatment. J Clin Psychiatry. 2010;71(7):e15.","journal-title":"J Clin Psychiatry"},{"key":"1523_CR19","unstructured":"ICC\/ESOMAR international code of market and social resesarch. \nhttps:\/\/www.esomar.org\/uploads\/public\/knowledge-and-standards\/codes-and-guidelines\/ICCESOMAR_Code_English_.pdf\n\n. Accessed 2 Feb 2017."},{"key":"1523_CR20","unstructured":"Code of ethics of the American Anthropological Association. \nhttp:\/\/s3.amazonaws.com\/rdcms-aaa\/files\/production\/public\/FileDownloads\/pdfs\/issues\/policy-advocacy\/upload\/AAA-Ethics-Code-2009.pdf\n\n. Accessed 2 Feb 2017."},{"key":"1523_CR21","unstructured":"C\u00f3digo de \u00c9tica da ABEP Associa\u00e7\u00e3o Brasileira de Empresas de Pesquisa (Code of ethics of ABEP Brazilian Association of Research Companies). \nhttp:\/\/www.demanda.com.br\/sitenovo\/pdfs\/CODIGO_DE_ETICA_DA_ABEP.pdf\n\n. Accessed 2 Feb 2017."},{"key":"1523_CR22","unstructured":"Principes g\u00e9n\u00e9raux de la pratique de la sociologie (General principles of the practice of sociology). \nhttp:\/\/www.test-afs-socio.fr\/drupal\/sites\/default\/files\/congres09\/FormCharte.html\n\n. Accessed 2 Feb 2017."},{"key":"1523_CR23","unstructured":"The \u201cFrankfurt Declaration\u201d of ethics in social and cultural anthropology. \nhttp:\/\/www.dgv-net.de\/wp-content\/uploads\/2016\/11\/DGV_Ethics-Declaration_FINAL_1.11.2016-1.pdf\n\n. Accessed 2 Feb 2017."},{"key":"1523_CR24","volume-title":"The moment of clarity: using the human sciences to solve your toughest business problems","author":"C Madsbjerg","year":"2014","unstructured":"Madsbjerg C, Rasmussen MB. The moment of clarity: using the human sciences to solve your toughest business problems. Cambridge: Harvard Business Review Press; 2014."},{"issue":"4","key":"1523_CR25","first-page":"775","volume":"47","author":"DO Dahlstrom","year":"1994","unstructured":"Dahlstrom DO. Heidegger's method: philosophical concepts as formal indications. Rev Metaphys. 1994;47(4):775\u201395.","journal-title":"Rev Metaphys"},{"key":"1523_CR26","volume-title":"The interpretations of cultures: selected essays","author":"C Geertz","year":"1973","unstructured":"Geertz C. The interpretations of cultures: selected essays. New York: Basic Books; 1973."},{"issue":"7","key":"1523_CR27","doi-asserted-by":"crossref","first-page":"A543","DOI":"10.1016\/j.jval.2013.08.1383","volume":"16","author":"D Saragoussi","year":"2013","unstructured":"Saragoussi D, Haro JM, Boulenger JP, J\u00f6nsson B, Knapp M, Caillou H, Chalem Y, Milea D, Fran\u00e7ois C. Patient-reported cognitive dysfunction negatively impacts functioning in patients with major depressive disorder \u2013 preliminary findings from the PERFORM study [PMH14]. Value Health. 2013;16(7):A543\u2013A4.","journal-title":"Value Health"},{"issue":"6","key":"1523_CR28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1600-0447.2008.01285.x","volume":"118","author":"MA Buist-Bouwman","year":"2008","unstructured":"Buist-Bouwman MA, Ormel J, de Graaf R, de Jonge P, van Sonderen E, Alonso J, Bruffaerts R, Vollebergh WA. Mediators of the association between depression and role functioning. Acta Psychiatr Scand. 2008;118(6):451\u20138.","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"1523_CR29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.euroneuro.2013.11.001","volume":"24","author":"W Belgaied","year":"2014","unstructured":"Belgaied W, Samp J, Vimont A, Remuzat C, Aballea S, El Hammi E, Kooli A, Toumi M, Akhras K. Routine clinical assessment of cognitive functioning in schizophrenia, major depressive disorder, and bipolar disorder. Eur Neuropsychopharmacol. 2014;24(1):133\u201341.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"S1","key":"1523_CR30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/S1092852915000826","volume":"20","author":"RS McIntyre","year":"2015","unstructured":"McIntyre RS, Lee Y, Mansur RB. Treating to target in major depressive disorder: response to remission to functional recovery [CME]. CNS Spectr. 2015;20(S1):17\u201331.","journal-title":"CNS Spectr"},{"issue":"2","key":"1523_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyv082","volume":"19","author":"JD Rosenblat","year":"2016","unstructured":"Rosenblat JD, Kakar R, McIntyre RS. The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials. Int J Neuropsychopharmacol. 2016;19(2):1\u201313.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"8","key":"1523_CR32","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/npp.2015.52","volume":"22","author":"AR Mahableshwarkar","year":"2015","unstructured":"Mahableshwarkar AR, Zajecka J, Jacobson W, Chen Y, Keefe RS. A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology. 2015;22(8):2025\u201337.","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"1523_CR33","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1017\/S1461145714000546","volume":"17","author":"RS McIntyre","year":"2014","unstructured":"McIntyre RS, Lophaven S, Olsen CK. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol. 2014;17(10):1557\u201367.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1523_CR34","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1016\/S0924-977X(12)70388-7","volume":"22","author":"C Katona","year":"2012","unstructured":"Katona C, Hansen T, Olsen CK. A randomised, double-blind, placebocontrolled, active-referenced study of the multimodal antidepressant Lu AA21004 in the treatment of elderly depressed patients. Eur Neuropsychopharmacol. 2012;22:S258\u2013S9.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"1523_CR35","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ajp.2007.164.6.900","volume":"164","author":"J Raskin","year":"2007","unstructured":"Raskin J, Wiltse CG, Siegal A, Sheikh J, Xu J, Dinkel JJ, Rotz BT, Mohs RC. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry. 2007;164(6):900\u20139.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1523_CR36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00004850-200301000-00002","volume":"18","author":"JM Ferguson","year":"2003","unstructured":"Ferguson JM, Wesnes KA, Schwartz GE. Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients. Int Clin Psychopharmacol. 2003;18(1):9\u201314.","journal-title":"Int Clin Psychopharmacol"},{"issue":"9","key":"1523_CR37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jpsychires.2008.10.015","volume":"43","author":"I Herrera-Guzman","year":"2009","unstructured":"Herrera-Guzman I, Gudayol-Ferre E, Herrera-Guzman D, Guardia-Olmos J, Hinojosa-Calvo E, Herrera-Abarca JE. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. J Psychiatr Res. 2009;43(9):855\u201363.","journal-title":"J Psychiatr Res"},{"issue":"6","key":"1523_CR38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/clpt.2013.39","volume":"93","author":"EL Theunissen","year":"2013","unstructured":"Theunissen EL, Street D, Hojer AM, Vermeeren A, van Oers A, Ramaekers JG. A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition. Clin Pharmacol Ther. 2013;93(6):493\u2013501.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1523_CR39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00702-012-0833-8","volume":"120","author":"A Brunnauer","year":"2013","unstructured":"Brunnauer A, Laux G. The effects of most commonly prescribed second generation antidepressants on driving ability: a systematic review: 70th birthday Prof. Riederer J Neural Transm. 2013;120(1):225\u201332.","journal-title":"Riederer J Neural Transm"},{"issue":"1","key":"1523_CR40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4088\/JCP.v64n0106","volume":"64","author":"JG Ramaekers","year":"2003","unstructured":"Ramaekers JG. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry. 2003;64(1):20\u20139.","journal-title":"J Clin Psychiatry"},{"key":"1523_CR41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jad.2015.10.059","volume":"190","author":"CV Ott","year":"2016","unstructured":"Ott CV, Bjertrup AJ, Jensen JH, Ullum H, Sj\u00e6lland R, Purdon SE, Vieta E, Kessing LV, Miskowiak KW. Screening for cognitive dysfunction in unipolar depression: validation and evaluation of objective and subjective tools. J Affect Disord. 2016;190:607\u201315.","journal-title":"J Affect Disord"},{"issue":"1","key":"1523_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-016-0815-8","volume":"16","author":"C Mohn","year":"2016","unstructured":"Mohn C, Rund BR. Neurocognitive profile in major depressive disorders: relationship to symptom level and subjective memory complaints. BMC Psychiatry. 2016;16(1):1\u20136.","journal-title":"BMC Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-017-1523-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T15:17:44Z","timestamp":1589815064000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-017-1523-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1523"],"URL":"https:\/\/doi.org\/10.1186\/s12888-017-1523-8","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]},"article-number":"370"}}